Alex Zhavoronkov
 | This article may contain wording that promotes the subject through exaggeration of unnoteworthy facts. (November 2017) (Learn how and when to remove this template message) |
| Alex Zhavoronkov | |
|---|---|
| Born | August 17, 1979 (age 38) Riga, Latvia |
| 🎓 Alma mater | Johns Hopkins University (JHU) |
| 💼 Occupation | |
| Known for | The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy |
Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine, and aging economics. He is the founder of Insilico Medicine,[1] the director of the Biogerontology Research Foundation,[2] a UK-based think-tank for aging research, and also the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is the adjunct professor at the Moscow Institute of Physics and Technology.[3]
Education[edit]
Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University.[4]
Career[edit]
He is the co-founder and CEO of Insilico Medicine, a deep learning company focused on drug discovery and biomarker development for aging and aging-associated diseases located at the Emerging Technology Centers of the Johns Hopkins University.[5][6]
Publications[edit]
Since 2011, Dr. Zhavoronkov authored and co-authored over 108 scientific articles published in refereed journals[7] with over 85 papers referenced in PubMed.[8] Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development, and aging research.[9] He has contributed articles on trends in aging and longevity for the popular press including Huffington Post,[10] Financial Times Pensions Expert,[11] Next Avenue,[12] and New Scientist.[13]
In November 2017 together with the collaborators from the BitFury Group he proposed the application of the deep learning techniques and blockchain technology for managing human life data[14] and presented the concept at the Singularity University Exponential Medicine conference in San Diego.[15][16]
Editorial roles and conferences[edit]
Dr. Zhavoronkov is the editor of Aging[17] and associate editor of Frontiers in Genetics of Aging.[18] He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors [19] as part of the EMBO/Basel Life.[20]
Books[edit]
- Zhavoronkov, Alex (2013). The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy. Macmillan. ISBN 978-0230342200. Search this book on
- Zhavoronkov, Alex (2012), Dating A.I.: A guide to falling in love with Artificial Intelligence, RE/Search, ISBN 978-1889307350
Patents[edit]
- US patent 8442626B2, Alex Zavoronkov, Mikhail Bakhnyan, "Systems and methods for communicating with a computer using brain activity patterns", issued May 14, 2013[28]
References[edit]
- ↑ Eric Smaley (2017). "AI-powered drug discovery captures pharma interest". Nature Biotechnology. 35 (7): 605. doi:10.1038/nbt0717-604. PMID 28700560.
- ↑ "Biogerontology Research Foundation Salutes Staff On Multi-Year Drug Development Agreement". Bioengineer.org. Retrieved 28 November 2017.
- ↑ MIPT MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017
- ↑ Executive Profile of Alexander Zhavoronkov Bloomberg.com
- ↑ GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014
- ↑ Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017
- ↑ Google Scholar by Publication Date Google Scholar by Publication Date
- ↑ PubMed Bibliography Pubmed
- ↑ Google Scholar by Citation Google Scholar by Citation
- ↑ Huffington Post: 13 Reasons Why We Will Live Longer Than Our Parents
- ↑ Financial Times Pensions Expert: A scheme guide to changing longevity risk
- ↑ Next Avenue, Why We Should Look Forward To Living To 120 And Beyond
- ↑ New Scientist
- ↑ Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research
- ↑ Alex Zhavoronkov presentation at the Exponential Medicine
- ↑ Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs
- ↑ Aging Editorial Board
- ↑ Frontiers in Genetics of Aging Editorial Board
- ↑ New Scientist report from the International Symposium on Geroprotectors in Basel
- ↑ 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland
- ↑ Scheffler, Daniel (July 9, 2013). "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review)".
- ↑ Bloomberg Business week, Critic 07.22.2013 pp. 74
- ↑ CBS Radio with Dan Raviv in Washington, DC
- ↑ Book Tour Radio
- ↑ Ageless Generation on Maruzen
- ↑ Ageless Generation in Polish
- ↑ Ageless Generation in Chinese
- ↑ Bobrov, P; Frolov, A; Cantor, C; Fedulova, I; Bakhnyan, M; Zhavoronkov, A (2011). "Brain-computer interface based on generation of visual images". PLoS ONE. 6 (6): e20674. doi:10.1371/journal.pone.0020674. PMC 3112189. PMID 21695206.
External links[edit]
- Editor biography at Frontiers
- ResearchGate profile
- ORCID ID
- Author profile at Amazon
- The Biogerontology Research Foundation
This article "Alex Zhavoronkov" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
